secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2022-10-24T23:59:59+00:00
Accession:  0000950170-22-019872
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma CMO Arturo Molina resigns; effective Nov 4, 2022
----------------------------------------------------------------

- Dr. Arturo Molina notified Sutro on Oct 18, 2022 of his resignation as Chief Medical Officer.
- Resignation effective November 4, 2022; no successor announced.
- Company states resignation not due to any disagreement with management or board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000095017022019872/0000950170-22-019872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000095017022019872/stro-20221018.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-019872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer